Aurinia Pharmaceuticals Inc's Comment on Supply Chain
Aurinia sources raw materials for the manufacture of voclosporin and has maintained sufficient inventory and manufacturing capacity to meet forecasted demand. In December 2020, Aurinia entered into a manufacturing services agreement with Lonza to construct the Monoplant, a dedicated facility for voclosporin production, which commenced operations in June 2023. Aurinia pays Lonza a quarterly fixed facility fee for exclusive use of the Monoplant through March 31, 2030. Catalent Pharma Solutions serves as the sole supplier for the preparation of voclosporin capsules under a supply agreement, and Aurinia anticipates continuing this contract manufacturing relationship. For blistering and packaging of LUPKYNIS commercial cartons for the U.S. market, Aurinia utilizes a sole supplier under a supply agreement and expects no disruptions in these services.
Aurinia Pharmaceuticals Inc's Comment on Supply Chain
Aurinia sources raw materials for the manufacture of voclosporin and has maintained sufficient inventory and manufacturing capacity to meet forecasted demand. In December 2020, Aurinia entered into a manufacturing services agreement with Lonza to construct the Monoplant, a dedicated facility for voclosporin production, which commenced operations in June 2023. Aurinia pays Lonza a quarterly fixed facility fee for exclusive use of the Monoplant through March 31, 2030. Catalent Pharma Solutions serves as the sole supplier for the preparation of voclosporin capsules under a supply agreement, and Aurinia anticipates continuing this contract manufacturing relationship. For blistering and packaging of LUPKYNIS commercial cartons for the U.S. market, Aurinia utilizes a sole supplier under a supply agreement and expects no disruptions in these services.
Sources:
Aurinia Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Aurinia Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
